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Abstract The metal-dependent activation of metallothionein 
(MT) genes requires the interaction of positive fra/w-activators 
(MRFs) with metal-regulatory (MRE) regions of MT promoters. 
In this report, we examined the role of transition metals in 
modulating the MRE-binding activities of two different MRE-
binding proteins: the metal-regulated factor ZiRFl and the basal 
factor SPI. We showed the ability of both proteins to interact 
with a similar sequence specificity with the cognate target site 
(MRE-S) of another known MRE-binding protein, mMTFl. We 
next evaluated the role of metal ions in modulating the MRE-
binding activity of recombinant ZiRFl and basal SPI proteins by 
measuring the effect of different metal chelators on DNA 
interaction. We observed a dose-dependent inhibition of the 
GST-ZiRFl/MRE-binding activity using three different metal 
chelators: EDTA, 1,10 PHE and TPEN. Interestingly, EDTA 
treatment failed to inhibit the recombinant SPI MRE-binding 
activity while the effect of 1,10 PHE was comparable to that 
obtained analyzing 1,10 РНЕ-treated GST-ZiRFl. The MRE-
binding complexes detected in cell extracts showed a response to 
metal chelator treatment very similar to that displayed by the 
recombinant ZiRFl and SPI proteins. The hypothesis of mutual 
interactions of both basal and metal-regulated transcription 
factors with the same metal-regulatory regions is discussed. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Metallothioneins (MTs) are small, cysteine-rich proteins 
which bind metal ions through thiol clusters. MTs are found 
in all eukaryotes and they are supposed to play an essential 
role in metal ion homeostasis and/or detoxification (for re-
views see [1-3]). Expression of the MT gene is transcription-
ally up-regulated upon cell exposure to various agents (gluco-
corticoids, polypeptide hormones, UV and others) and metal 
ions belonging to the IB and IIB groups [4,5]. Metal induction 
of MTs is conferred by conserved, short, 12-bp sequences 
known as metal-regulating elements (MREs). MREs are 
present in multiple imperfect copies in all the promoter re-
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gions of MT genes [6,7]. Functional analysis of these regions 
and in vivo genomic footprinting experiments have suggested 
the metal-dependent interaction of putative /rans-acting met-
al-responsive factors (MRFs) with the MREs and that these 
factors could act as activators of gene transcription and not as 
repressore [8,9]. 
Various putative MRFs have so far been identified but the 
mechanisms which trigger the metal-dependent MT gene ex-
pression are still unclear [10-14]. All of these factors bind in a 
metal-dependent manner and could be responsible for the 
metal-induced transcription of MTs. The mouse MTF-I [15] 
is the most extensively studied MRE-binding protein. mMTFl 
is a zinc-finger protein that was cloned for its ability to bind 
the synthetic MRE-S oligonucleotide. Interestingly, the inac-
tivation of the MTF1 gene in mouse ES cells abolished both 
basal and inducible MT gene expression suggesting a func-
tional role of this factor in the regulation of MT gene expres-
sion [16]. We isolated a distinct mouse factor, the zinc-regu-
lated factor ZiRFl, for its ability to activate MRE-driven 
reporter genes in yeast cells [17]. ZiRFl has the ability to 
exhibit zinc-dependent binding in vitro to MREs which are 
functional in vivo. Recently, we reported that the basal SPI 
displays MRE-binding properties similar to ZiRFl [18]. These 
results indicated that both metal-regulated and basal factors 
could interact with the same metal-regulatory sequences. In 
this report, we examined the role of metal ions in modulating 
the MRE interactions of both the metal-regulated factor 
ZiRFl and the basal transcription activator SPI, and their 
ability to interact with the MTF1 site, MRE-S. 
2. Materials and methods 
2.1. Reagents 
Chemicals were obtained from E. Merck (Darmstadt, Germany) 
and Sigma Chemicals (St. Louis, MO, USA). Tissue culture reagents 
were supplied by Gibco BRL (Inchinan, UK). TPEN was obtained 
from Molecular Probes Inc. (Eugene, OR, USA). γ-[32Ρ]ΑΤΡ (specific 
activity 3000 Ci/mmol) was from Du Pont-New England Nuclear 
(Boston, MA, USA). Restriction enzymes were purchased from New 
England Bio Labs (Beverly, MA, USA). Plasmid vectors were ob-
tained from Invitrogen (La Jolla, CA, USA) and Stratagene (La Jolla, 
С A, USA). Glutathione Sepharose 4B was from Pharmacia (Uppsala, 
Sweden). Oligonucleotides were synthesized by Primm (Milan, Italy). 
The human recombinant SPI was purchased from Promega (Madison, 
WI, USA). 
2.2. Cell culture and media 
Mouse L fibroblasts were cultured in MEM supplemented with 10% 
FBS, 100 U/ml penicillin, 50 μg/ml streptomycin and 2 mM L-gluta-
mine. 
2.3. Protein expression and metal chelator treatment 
Escherichia coli strain XI1 blue was transformed with pGEX-ZiRFl 
expression vector [18], grown at 37°C in liquid broth (LB) and col-
lected at a density range of ODeoo = 0.6-0.8. Expression of the GST-
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ZiRFl fusion protein was obtained by adding 0.1 mM IPTG for 4 h 
at 30°C to the cell cultures; cells were harvested with 1/20 volume of 
PBS containing 2 mM DTT and protease inhibitors (2 μg/ml aproti-
nin, pepstatin A, leupeptin, chymostatin and 1 mM PMSF), sonicated 
4 X 20 s and spun at 4°C, 30 000 rpm for 30 min. The supernatant was 
then adjusted to 1% Triton and incubated with GSH-Sepharose 4B 
beads for 1 h at 4°C. Proteins bound to the beads were eluted with a 
buffer containing 5 mM GSH/50 mM Tris-Cl pH 8.0/100 mM NaCl/2 
mM DTT. Further dialysis was used to remove free GSH. 
Metal depletion by 1,10 PHE, EDTA and TPEN was obtained by 
dialysis of proteins in PBS buffer containing metal chelators at the 
indicated doses for 3 h at 4°C. Chemicals were subsequently removed 
by a second dialysis with PBS. 
2.4. Mobility shift assays 
Synthetic oligonucleotides corresponding to the MRE3/4 and MRE-
S regions (for sequences see Fig. 1) were 32P end-labeled with T4 
polynucleotide kinase, annealed and incubated with 0.5-1.0 ng of 
partially purified recombinant GST-ZiRFl fusion protein, in binding 
buffer containing 12% glycerol/12 mM HEPES-NaOH pH 7.9/50 mM 
KC1/5 mM Tris-HCl pH 7.9/100 ng bovine serum albumin (BSA)/0.1 
μg poly(dFdT)/l mM DTT in a volume of 20 μΐ [17]. Binding reac-
tions were incubated for 45 min on ice and samples were layered on 
low-ionic-strength 6% polyacrylamide gel (acrylamide/bis-acrylamide, 
28:2). Gels were pre-electrophoresed for 1 h at 15 mA in 22.5 mM 
Tris-borate pH 8.3/0.5 mM EDTA and samples were electrophoresed 
for 3 h at 4°C. Competition experiments were performed by adding 
unlabeled oligonucleotides before the addition of the protein. 
Analysis of the human recombinant SPI [19] was performed by 
assaying 1 footprinting unit (fpu) of human recombinant SPI 
(hrSPl) per binding reaction. 
Nuclear extracts were prepared as previously described [20] and 
binding reactions were performed under the same conditions as de-
scribed for the recombinant proteins, except that 4 μg of nuclear 
proteins were assayed in a reaction buffer containing 1 μg of poly-
(dFdCypo^dA-dT), 1:1 mix. All figures display representative ex-
periments that were repeated at least three times. 
3. Results 
Fig. 2. Recombinant GST-ZiRFl and SPI factors bind the mMTFl 
site MRE-S. A: Mobility shift assays were performed using the re-
combinant GST-ZiRFl fusion protein and 32P-labeled MRE-S as 
probe; lane 1, no added protein; lanes 2-10, 10 ng of bacterial ex-
pressed GST-ZiRFl. 20- and 200-fold molar excess of the cold com-
petitors MRE-S (lanes 3^1), MREd/c (lanes 5-6), mutG2 (lanes 7-8) 
and SP1-HSV (lanes 9-10). B: Binding of the human recombinant 
SPI to the 32P-labeled MRE-S oligonucleotide. Lane 1, no added 
protein; lanes 2-10, 1 fpu (footprinting unit) of hrSPl protein; 
lanes 3-10, same amounts of competitors as in A. 
3.1. ZiRFl and SPI factors bind the high-affinity MTF1 site, 
MRE-S 
We investigated the possibility that metal-regulated ZiRFl 
and basal SPI factors could interact with different MRE se-
quences, including the high-affinity mMTFl-binding site, 
MRE-S (Fig. 1). Mobility shift assays showed binding of 
M R E d / c 5 ' - AATTGTCTGCACTCCOCeCGAAAAGTGCGCTCGG - 3 ' 
S P I 
M R E 3 / 4 5 ' - AATTCGOTGCBCCCGGCCCAGTGCGCGCGGCCG - 3 ' 
S P I 
- S 5 ' - CGAGGGAGCTCTGCACA£SS££ffiAAAAGT - 3 ' 
S P I 
m u t G 2 5 ' - AATTCTCTGCACTCCGTCTGAAAAGTGCGCTCGG - 3 ' 
m u t M R E 5 ' - AATTCGGAATGTCAGGCCCAGAATGTGAGGCCG - 3 ' 
S P - H S V CCGGCCCCGCCCATCCCCGGCCCCGCCCATCC - 3 ' 
Fig. 1. Sequences of the synthetic oligonucleotides. MREd/c was 
synthesized according to the mouse MTI promoter sequence span-
ning from position —150 to —123 [5]; MRE3/4 was obtained by the 
synthesis of the 5' region of the hMTIIa promoter spanning from 
nucleotides —147 to —112 [9]. In mutG2 mutated nucleotides are in-
dicated in bold. The MRE-S sequence was designed as reported by 
Radtke et al. [15]. The multiple SPl-binding site, SP-HSV, was ob-
tained by synthesizing the SPl-binding sites present in the promoter 
of the herpes simplex virus immediate-early 3 (HSV IE-3) gene 
[15,19]. Synthetic MREs were synthesized with an EcoKl site at 
both ends. Overlines correspond to MRE core elements; underlined 
sequences correspond to SPl-like sites. 
GST-ZiRFl fusion protein to the 32P-labeled MRE-S (Fig. 
2A, lane 2). Therefore, we performed competition experiments 
to determine if the DNA-protein complexes were specific. In-
teraction of GST-ZiRFl with MRE-S was inhibited more 
efficiently by the naturally occurring MREd/c (Fig. 2A, lanes 
5-6) than by self-competition with the synthetic MRE-S (Fig. 
2A, lanes 3^1). Sequences of competitor DNAs are reported 
in Fig. 1. Conversely, incubation with 20- and 200-fold molar 
excess of the point-mutated MREd/c, mutG2, did not affect 
the ZiRFl/MRE-S interaction (Fig. 2A, lanes 7-8). Further-
more, we observed that the multiple SPl-binding site, SP-
HSV, was able to displace the complex as well as the wild-
type MREd/c (Fig. 2A, compare lanes 5-6 with lanes 9-10). 
We next compared the MRE-binding activity of the metal-
regulated ZiRFl and the basal SPI factor by performing a 
similar analysis with hrSPl. As measured by mobility shift 
analysis, hrSPl was also able to bind MRE-S (Fig. 2B, lanes 
2-4). The results of competition assays were similar to those 
displayed by GST-ZiRFl (compare Fig. 2B with Fig. 2A, 
lanes 3-10)). The SP1/MRE-S complex was displaced by 
self-competition with MRE-S (Fig. 2B, lanes 3^1) and by 
the wild-type metal-regulating MREd/c (Fig. 2B, lanes 5-6). 
The effects of incubation with cold SP-HSV and mutG2 also 
overlapped with those obtained in ZiRFl-MRE-S analysis 
(compare Figs. 2A and 2B, lanes 7-10). These results con-
firmed that the basal SPI transcription factor exhibits MRE 
recognition properties very similar to those evidenced for the 
metal-regulated ZiRFl and mMTFl. 
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3.2. Dose-dependent inhibition of ZiRFllMRE binding by 
metal chelator treatment 
We next tested the possibility that the interaction of GST-
ZiRFl with the MREs was metal-dependent. We therefore 
performed mobility shift assays to measure the effect of 1,10 
phenanthroline (1,10 PHE) and of its isomer 1,7 phenanthro-
line (1,7 PHE) which lacks the ability to bind divalent cations. 
By treating purified GST-ZiRFl fusion protein with 1,10 PHE 
we obtained inhibition of its binding to MRE3/4 (Fig. ЗА, 
lanes 7-10). This effect was dose-dependent and started at 
metal chelator concentrations of 200 μΜ. The higher inhib-
itory effects were observed at doses of 1,10 PHE ranging be-
tween 1 (Fig. ЗА, lane 10) and 2 mM (data not shown). 
Conversely, we did not find inhibition of GST-ZiRFl pro-
tein-binding activity using the non-metal-binding 1,7 PHE as 
a control (Fig. ЗА, lanes 2-6). 
Analyses of the metal requirement of the GST-ZiRFl/MRE 
complexes were confirmed by binding assays of the recombi-
nant protein dialyzed in the presence of increasing concentra-
tions of EDTA or the high-affinity zinc chelator TPEN. GST-
ZiRFl/MRE binding was inactivated in a dose-dependent 
manner by both EDTA (Fig. 3B, lanes 2-4) and TPEN 
Fig. 4. Effect of metal depletion on hrSPl/MRE interaction. Binding 
of human recombinant SPI to 32P-labeled MRE3/4 was measured 
by mobility shift assays following metal depletion with EDTA or 
1,10 PHE. Lane 1, no added protein; lane 2, untreated protein; 
lanes 3-6, hrSPl treated with EDTA for 1 h; lanes 7-10, 1,10 
РНЕ-treated protein. Concentrations of metal chelators are ex-
pressed in mM. Arrows indicate hrSPl/MRE complexes and the un-
bound probe, F. 
(Fig. 3B, lanes 5-7); in all the experiments we performed, 
we observed a stronger inhibition of TPEN compared with 
EDTA. 
3.3. Metal-dependent MRE-binding activity of recombinant 
SPI 
In order to evaluate the role of metal ions in modulating 
the binding of metal-regulated and/or basal SPI transcription 
factor to the MREs, we extended the analysis of metal re-
quirement to the complexes formed by the recombinant 
hrSPl with the MRE3/4 human MTIIa promoter region 
(Fig. 4, lane 2). The MRE-binding activity of hrSPl was 
measured by mobility shift assay using the recombinant SPI 
protein treated with different concentration of EDTA (Fig. 4, 
lanes 3-6). We found that EDTA treatment lacked the ability 
to interfere with the binding of hrSPl to the human MRE3/4 
region when we used concentrations ranging between 0.2 and 
2.0 mM (Fig. 4, lanes 3-5). Conversely, treatment of recombi-
nant SPI with 1,10 PHE decreased the intensity of the bands 
corresponding to the SP1/MRE complexes, giving a maximal 
effect at 2 mM (Fig. 4, lanes 7-10). Similar results were ob-
tained with TPEN treatment, although in this case the inacti-
vation was weaker than with 1,10 PHE treatment (data not 
shown). 
We therefore found that also the basal SPI binding activity 
to the MRE3/4 was metal-dependent, but that this complex 
was more resistant to EDTA treatment than that formed by 
the metal-regulated GST-ZiRFl activator. 
Fig. 3. Effect of metal depletion on GST-ZRF1/MRE interaction. 
A: Mobility shift assays of partially purified GST-ZiRFl protein to 
32P-labeled MRE3/4 following dialysis with 1,7 PHE or 1,10 PHE. 
Lane 1, no added protein; lane 2, untreated protein; lanes 3-6, 
GST-ZiRFl protein treated with 1,7 PHE; lanes 7-10, GST-ZiRFl 
protein treated with 1,10 PHE. B; Binding of GST-ZiRFl protein 
to 32P-labeled MRE3/4 after metal depletion by EDTA or TPEN. 
Lane 1, untreated protein; lanes 2-4, EDTA-treated protein; lanes 
5-7, TPEN-treated protein. Doses of metal chelators are indicated 
in mM. Arrows indicate GST-ZiRFl/MRE complex and the un-
bound probe, F. 
3.4. Metal chelators inhibit the formation of the MRE-binding 
complexes detected in nuclear extracts 
Analysis of nuclear extracts derived from mouse L cells 
revealed MRE-binding complexes (MBC) with distinct molec-
ular weights (Fig. 5, lane 2). Our previous studies suggested 
that higher-Mr complexes were more likely composed of SPI 
or similar proteins, while the faster-migrating MBC was com-
posed of ZiRFl [18]. To further examine the role of metal 
ions in regulating DNA interaction of MRE-binding proteins, 
we treated cell extracts with increasing concentrations of dif-
ferent metal chelators and measured the effect of metal deple-
tion on MBC formation by the use of mobility shift assays. 
Interestingly, only the faster MRE-binding complex (MBQ) 
was inactivated by EDTA (Fig. 5, lane 5) and the inhibition 
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Fig. 5. Effect of metal depletion on nuclear cell extracts having 
MRE-binding activities. Nuclear proteins were treated with EDTA 
and analyzed in mobility shift assays for their ability to bind the 
32P-labeled MRE3/4 oligomer. Lane 1, no added proteins; lane 2, 
untreated L cell nuclear extracts. Nuclear extracts dialyzed with: 
EDTA (lanes 3-5); 1,10 PHE (lanes 6-8); TPEN (lanes 9-11). The 
concentrations used for the metal chelating treatment are given in 
mM. Arrows indicate MRE-binding complexes (MBCs) and the un-
bound probe, F. 
observed was dose-dependent (Fig. 5, lanes 2-5). Higher-Afr 
complexes (MBC2 and MBC3) were not affected by EDTA. 
Conversely, treatment with 1,10 PHE strongly interfered with 
all the MRE-binding complexes detected (Fig. 5A, lanes 6-8) ; 
TPEN treatment gave a similar effect, although inhibition of 
the higher-Mr complexes MBC2 and MBC3 occurred only at 
higher doses when compared to 1,10 PHE (Fig. 5A, lanes 9-
11). 
4. Discussion 
We previously demonstrated the specific interactions of 
both the zinc-regulated factor ZiRFl and the basal SPI 
with the MREd/c region of the mouse MTI promoter [18]. 
Our results showed very high similarities between ZiRFl 
and SPI in the ability to recognize functional MREs. 
In this paper, we extend those observations to the charac-
terization of DNA binding of the two purified transcription 
factors, ZiRFl and SPI, to different MRE sequences and the 
role of metal ions in modulating their DNA interactions. 
We found that both purified GST-ZiRFl and SPI proteins 
display similar binding properties for MRE and SPI target 
sites in gel retardation assays. Our results show that ZiRFl 
interacts more strongly with the naturally occurring MREd/c 
than with the synthetic MRE-S, the recognition site for the 
previously cloned mouse factor MTF1 [15]. A role of mMTFl 
in the regulation of MT gene expression was established by 
the finding that expression of MT genes was silent in ES cells 
where the mMTFl gene was inactivated [16]. However, a 
number of lines of evidence suggest that different metal-regu-
lated factors could interact with common binding sites [10-
15,18]. Our results showed that ZiRFl has the ability to in-
teract specifically also with MRE-S and this indicates that 
metal-regulated ZiRFl and mMTFl factors could compete 
for the same regulatory sites. The ability of ZiRFl protein 
to recognize the mMTFl target site supports the hypothesis 
that the metal-dependent activation of MT genes could in-
volve transcription factors having different responses or acti-
vation properties upon metal induction [21]. 
We also found that in addition to the metal-regulated 
mMTFl and ZiRFl factors the basal SPI transcription acti-
vator was also able to bind MRE-S with a comparable se-
quence specificity (Fig. 2B). Our results confirm the finding 
that metal-regulated and basal factors could interact with the 
same metal-regulatory sequences [8,18] and suggest that the 
regulation of the expression of MT genes by metals might be 
modulated by competition between the two groups of tran-
scription activators for the same cognate site. 
We next analyzed the role of metals in the binding of recombi-
nant ZiRFl [18] and SPI [19] proteins to MRE sequences. 
The three metal chelators, EDTA, 1,10 PHE and TPEN, 
gave a dose-dependent inhibition of GST-ZiRFl MRE3/4-
binding activity. The specificity of the effect of metal depletion 
is demonstrated by the inability of the non-functional analog, 
1,7 PHE, to interfere with the DNA-protein interaction. We 
also observed that the ZiRFl MRE-binding activity is more 
efficiently inhibited by TPEN as compared to EDTA. This 
could be due to the higher stability of the TPEN metal-bound 
complex and/or to the more efficient ability of the chelator to 
access the ZiRFl metal-binding clusters. The metal depend-
ence of ZiRFl in binding to MRE sequences and our previous 
observations [18] propose for this nuclear factor a mechanism 
similar to the yeast transactivator ACE 1/CUPI [22,23] in 
which the metal (zinc in the case of ZiRFl) could directly 
modulate the interaction of the apoprotein with the metal-
regulatory regions. 
Previous studies have already shown that SPI is a metal-
bound protein that requires zinc ions for its interaction with 
DNA [24]. Our results showed the inability of EDTA to in-
hibit the SPl-MRE3/4-binding activity, supporting the hy-
pothesis that the metal depletion of SPI is possible only in 
denaturing conditions, which allow the access of the metal 
chelator to the metal-binding domains present in the factor. 
Conversely, the chelating effect of 1,10 PHE was comparable 
on both SPI and ZiRFl. 
We previously showed the presence in mouse cell extracts of 
a zinc-dependent MRE binding activity (MBC) with DNA 
recognition properties similar to those displayed by ZiRFl 
which cross-reacts with antibodies raised against purified 
GST-ZiRFl [18]. In addition, we showed that higher-Afr 
MRE-binding complexes were presumably composed of SPI 
or similar proteins. We now report that such detected MBCs 
give a different response to metal chelator treatment, similar 
to that observed assaying the purified SPI and ZiRFl pro-
teins, i.e. EDTA inactivated only the faster MBCi complex in 
a dose-dependent manner, while all three MBC complexes, 
MBCi, MBC2 and MBC3, were affected by 1,10 PHE and 
TPEN. 
These results suggest a different molecular composition or 
chemical properties of the MBCs, possibly by mutual inter-
actions of basal and metal-dependent transactivators. 
We also observed down-regulation of the hMTTIIa pro-
moter-CAT fusion plasmid in both non-induced and zinc-in-
duced transfected cells expressing antisense ZiRFl cDNA (P. 
Remondelli, unpublished results), although the effect was 
never complete. The consistent levels of hMTIIa promoter 
activity which are still detected upon antisense expression 
could be explained either by an incomplete inhibition of 
ZiRFl endogenous expression or by the possibility that differ-
ent factors may modulate the metal-dependent activation of 
MT promoters. 
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